| Literature DB >> 36103411 |
Lingyue Hua1,2,3,4, Wei Chen1,2,3,4, Yan Meng5, Meng Qin1,2,3,4, Zhiqiang Yan1,2,3,4, Rui Yang1,2,3,4, Qiang Liu1,2,3,4, Yuan Wei2,6,7, Yangyu Zhao2,6,7, Liying Yan1,2,3,4, Jie Qiao1,2,3,4,6,8,9,10.
Abstract
BACKGROUND: The number of women delivering at advanced maternal age (AMA; > = 35) continuously increases in developed and high-income countries. Large cohort studies have associated AMA with increased risks of various pregnancy complications and adverse pregnancy outcomes, which raises great concerns about the adverse effect of AMA on the long-term health of offspring. Specific acquired characteristics of parents can be passed on to descendants through certain molecular mechanisms, yet the underlying connection between AMA-related alterations in parents and that in offspring remains largely uncharted.Entities:
Keywords: DNA methylation; advanced maternal age; intergenerational inheritance; transcriptome
Mesh:
Substances:
Year: 2022 PMID: 36103411 PMCID: PMC9473489 DOI: 10.1002/ctm2.990
Source DB: PubMed Journal: Clin Transl Med ISSN: 2001-1326
FIGURE 1Distinct advanced maternal age (AMA)‐related DNA methylation changes in the mother and father groups. (A) Flowchart of the experiment and data analysis. (B) Three‐dimensional scatter plot showing the distribution of parental samples in the four groups (AMA‐mother, Young‐mother, AMA‐father, Young‐father). The first three principal components from principal components analysis (PCA) based on the 200 bp tiles DNA methylation pattern (n = 701937) were used; sample size: n = 40. (C) Box plot showing the distribution of DNA methylation level in four groups. Each dot represents the average DNA methylation level of each sample; the p value between AMA and Young groups was determined by Wilcoxon rank‐sum test. (ns: p > .05); the p value for the comparison among multiple groups was determined by Kruskal–Wallis test. (D) Mean DNA methylation levels along with the gene bodies, and 15 kilobases (kb) upstream of the transcription start site (TSS) and 15 kb downstream of the transcription end site (TES) of all genes. (E) Box plot presenting the distribution of the average DNA methylation level of specific genome elements in the AMA‐mother group (red) and Young‐mother group (blue); each dot represents the average DNA methylation level for each sample; the p value between the AMA and Young groups was determined by the Wilcoxon rank‐sum test. (F) Heatmap showing the DNA methylation of AMA‐related differentially methylated regions (DMR) in the mother group (left) and father group (right). Blue bars represent the Young group, and red bars represent the AMA group. Orange bars represent hyper DMRs, while green bars represent hypo DMRs. (G) Venn diagram showing the numbers of overlapping and nonoverlapped DMRs among the four groups; the corresponding relative genic location and nearby gene for each DMR in the targeted categories are presented on the left. Distal stands for distal intergenic. (H, I) Venn diagram showing the number of intersections between genes provided by the genAge database and genes near AMA‐DMRs in either the mother groups (H) or the father group (I). (J) Venn diagram showing the number of intersections between genes near AMA‐DMRs and senescence‐associated secretory phenotype genes in the mother groups. The relative genic locations and concrete genomic coordinates for the corresponding DMRs of overlapping genes are presented on the right (ns: p > .05, ∗p < .05; ∗∗p < .01, ∗∗∗p < .001).
FIGURE 2Advanced maternal age (AMA)‐related DNA methylation changes in offspring. (A) Three‐dimensional scatter plot showing the distribution of neonatal samples in the AMA and Young groups (sample size: n = 20); the first three principal components of PCA based on the 200 bp tiles DNA methylation pattern (n = 701937) were used. (B) Box plot showing the distribution of the mean DNA methylation level in the AMA and Young groups; each dot represents the average DNA methylation level of the corresponding sample; the p value between the AMA and Young groups was examined by the Wilcoxon rank‐sum test. (ns: p > .05). (C) Average DNA methylation levels of the gene bodies, and 15 kb upstream of the TSS and 15 kb downstream of the TES of all genes for each sample. (D) Box plot showing the distribution of the average DNA methylation level of specific genome elements as mentioned in Figure 1E in the AMA (red) and Young groups (blue); each dot represents the average DNA methylation level for each sample; the p value between the AMA and Young groups was determined by the Wilcoxon rank‐sum test. (E) Heatmap showing the DNA methylation level in the AMA‐related differentially methylated regions (DMRs) of the AMA offspring group and Young offspring group. Blue bars represent the Young group, and red bars represent the AMA group. The orange bars represent the hyper DMRs, while the green bars represent the hypo DMRs. (F) Column graph showing the proportion of AMA‐DMRs in different genomic features. (G) Venn diagram showing the intersection of genes provided by the genAge database and genes near AMA‐DMRs. (H) Venn diagram showing the intersection of genes near AMA‐DMRs and senescence‐associated secretory phenotype genes. The relative genic locations and concrete genomic coordinates for the corresponding DMRs of overlapping genes are presented on the right. (I) UpSet plot revealing the relationship among six lists of AMA‐DMRs in father groups, mother groups and offspring groups. Bar plots on the left and top represent the number of DMRs in the corresponding group. MK‐common DMRs are DMRs identified as common between the mother and offspring groups; FK‐common DMRs are DMRs identified as common between the father and offspring groups; FMK‐common are DMRs identified as common among the mother, father and offspring groups.
FIGURE 3Advanced maternal age (AMA)‐related transcriptional alterations in the mother and offspring. (A, B) Volcano plot simultaneously displaying the p value and the fold change in gene expression level in the comparison between the AMA and Young groups for either the mother (A) or offspring (B) groups. Red dots and blue dots represent the upregulated and downregulated DEGs identified between the AMA group and Young group; light grey dots refer to genes with no significant change. (C) Venn diagrams displaying the number of overlapping or no‐overlapping AMA‐DEGs between the mother and offspring groups (left), and the number of intersections between senescence‐associated secretory phenotype genes and common DEGs in mother and offspring groups (right). (D) Bubble chart showing representative Gene Ontology (GO) terms for common AMA‐DEGs mentioned in (C). The gene number in all enrichment terms was not less than three, with a p value < .05. The p value was measured by hypergeometric test. (E–G) Heatmap showing the DNA methylation level of AMA‐related (differentially methylated regions) DMRs whose nearest genes belonged to AMA‐DEGs in either the offspring group (E) or in the mother group (G, left) or the gene expression level of AMA‐DEGs overlapped with genes near AMA‐DMRs in either the offspring group (F) or in the mother group (G, right). Blue bars indicate the Young group, and red bars indicate the AMA group. Gray and orange bars indicate Up‐DEGs overlapping with genes near hypo DMRs and genes near hyper DMRs, respectively. Green and purple bars indicate Down‐DEGs overlapping with genes near hypo DMRs and genes near hyper DMRs, respectively. (H) Box diagram showing the gene expression level of SLC28A3 in the four groups (AMA‐Offspring, Young‐Offspring, AMA‐mother, Young‐mother). (I) Column diagram displaying the relative gene expression level of SLC28A3 determined by qRT‐PCR in the AMA and Young groups for either neonatal samples (left) or maternal samples (right). Each dot represents the relative gene expression level of each sample; error bars refer to the standard deviation. The p value between the AMA and Young groups was determined by unpaired t‐test (∗p < .05).
FIGURE 4Intergenerational correlation of advanced maternal age (AMA)‐related changes in either the DNA methylome or transcriptome. (A) Column diagram displaying the relative gene expression levels of CD24 determined by qRT‐PCR in the AMA and Young groups for either neonatal samples or maternal samples. Each dot represents the relative gene expression level of each sample. Error bars refer to the standard deviation. The p value between AMA and Young groups was calculated by unpaired t test. (∗p < .05; ∗∗p < .01; ∗∗∗p < .001). (B) Scatter diagram showing the relative gene expression level determined by qRT‐PCR for CD24 in paired maternal and neonatal samples. The blue straight line is the fitted linear regression line. Each dot represents a family. AMA families are shown in red, and Young families are in blue. The correlation coefficient and p value between the mother and offspring groups were calculated by Spearman‐based correlation tests. The shadow indicates the 0.95 confidence level interval around the fitted linear regression line; n = 10. (C) Bar graph showing the number of intergenerational and no‐intergenerational correlated differentially methylated regions (DMRs) in either MK‐common DMRs or FK‐common DMRs identified in Figure 2I, as well as the number of intergenerational and no‐intergenerational correlated DEGs in MK‐common DEGs as mentioned in Figure 3C. (D) Heatmap (right) showing the raw average DNA methylation level in different stages of early embryo development for each intergenerationally correlated DMR. Heatmap (left) and line graph showing the scaled average DNA methylation level in different stages of early embryo development for each intergenerationally correlated DMRs. Each DMR was expanded to an additional 150 bp upstream and downstream. Only expanded DMRs covering more than three CpGs in DNA methylome data of early embryo development were analysed. Red dot in each stage refer to the median value of the scaled DNA methylation level of different DMRs. K‐means clustering based on the methylation dynamic pattern was performed to cluster those DMRs. (E) Heatmap and line graph showing the scaled average gene expression level in different stages of human oogenesis for each detected intergenerationally correlated DEGs. Red dot in each stage referred to the median value of scaled gene expression level of different DEGs. K‐means clustering based on the expression pattern was applied to classify those genes. (F) Heatmap showing the scaled gene expression level in each cell during early embryo development for each detected intergenerationally correlated DEG. K‐means clustering based on the expression pattern is applied to classify those genes. Curve chart in the right showing the loess‐smoothed row‐scaled expression dynamics pattern for genes in selected six different clusters. The shadow denotes the 0.95 confidence level interval around the fitting curves. For specific cluster, each point refers to the median of row‐scaled expression value of DEGs in each cell.
FIGURE 5Interrelationship among advanced maternal age (AMA)‐related transcriptional alterations in the mother, offspring, MII oocyte and blastocyst. (A) Venn diagrams displaying the number of intersections for five lists of AMA‐related DEGs from our maternal blood data, cord blood data, one published MII oocyte data and two published cry blastocyst data. Bar graph showing the total number of DEGs in each dataset. The top panel shows upregulated DEGs, while the bottom panel shows downregulated DEGs. (B) Scatter diagram showing the gene expression levels of HTRA3 in paired maternal and neonatal samples. The blue straight line refers to the fitted linear regression line. The correlation coefficient and p value between the mother and offspring groups were calculated by Spearman‐based correlation tests. (C) Box diagram showing the gene expression of HTRA3 in four groups (AMA‐Offspring, Young‐Offspring, AMA‐Mother and Young‐Mother) (D) Line diagram showing the gene expression dynamics of HTRA3 during oogenesis and early embryo development. (E) Scatter diagram showing the relative gene expression level determined by qRT‐PCR for HTRA3 in paired maternal and neonatal samples. The blue straight line is the fitted linear regression line. Each dot represents a family. AMA families are shown in red, and Young families are in blue. The correlation coefficient and p value between the mother and offspring groups were calculated by Spearman‐based correlation tests. The shadow indicates the 0.95 confidence level interval around the fitted linear regression line; n = 10. (F) Column diagram displaying the relative gene expression levels of HTRA3 determined by qRT‐PCR in the AMA and Young groups for either neonatal samples or maternal samples. Each dot represents the relative gene expression level of each sample. Error bars refer to the standard deviation. The p value between AMA and Young groups was calculated by unpaired t‐test. (∗p < .05; ∗∗p < .01; ∗∗∗p < .001). (G) A schematic illustration showing the close connection between mother and offspring for the AMA‐related alterations in either transcriptome or DNA methylome. The AMA‐related alteration in three genes:SLC28A3, CD24 and HTRA3 represents three typical patterns for intergenerationally correlated AMA‐DEGs mentioned in our study, respectively. AMA's impact on pregnant women will induce abnormal fluctuations in specific gene expression (such as HTRA3) in MII oocytes or preimplantation embryos, thus contributing to the similar changes observed in offspring. (H) A schematic diagram showing the interrelationship between AMA, AMA‐related maternal molecular change, AMA‐related offspring molecular change, and disease risk. AMA induced adverse changes on the mother and resulted in the increased risk of pregnant complications. The inheritable part of maternal changes, together with paternal impact and other external factors, lead to abnormal molecular changes in offspring and further influence their long‐term health.